Anthropic Long-Term Benefit Trust appoints Novartis CEO Vas Narasimhan to Board

Anthropic's Long-Term Benefit Trust appointed Vas Narasimhan, CEO of Novartis, to its Board of Directors. Narasimhan brings experience overseeing 35+ novel medicines in a highly regulated industry, aligning with Anthropic's focus on safe AI deployment. With his appointment, Trust-appointed directors now hold a majority on the Board, reinforcing governance balance between financial success and public benefit mission.

• #anthropic
• #board-of-directors
• #vas-narasimhan
• #long-term-benefit-trust
• #governance